Stay updated with breaking news from Daniel Marks. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Researchers at Oregon State University and Oregon Health & Science University have developed a promising, first-of-its-kind messenger RNA therapy for ovarian cancer as well as cachexia, a muscle-wasting condition associated
Researchers at Oregon State University and Oregon Health & Science University have developed a promising, first-of-its-kind messenger RNA therapy for ovarian cancer as well as cachexia, a muscle-wasting condition associated with cancer and other chronic illnesses.
The newly developed treatment is based on the same principles used in COVID vaccines.
Treat yourself and raise money for Father & Son Day with this one-of-a-kind auction from MatchesFashion and Acqua di Parma.
Here's a selection of recent executive hires across healthcare and life sciences.